Short Synthesis of Molnupiravir (EIDD-2801) via a Thionated Uridine Intermediate
Molnupiravir (MK-4482, EIDD-2801) is an experimental drug that has been demonstrated to
be effective for the treatment of COVID-19 in human clinical trials. Herein, we report a
concise synthesis of the drug via a novel thionated derivative that relies on one-pot
methodologies, thus decreasing the number of purification steps required. This route
provides the drug in an overall 62% yield and> 99% purity and uses cheap and readily
available bulk chemicals, thereby providing an affordable synthesis of the drug for cheaper …
be effective for the treatment of COVID-19 in human clinical trials. Herein, we report a
concise synthesis of the drug via a novel thionated derivative that relies on one-pot
methodologies, thus decreasing the number of purification steps required. This route
provides the drug in an overall 62% yield and> 99% purity and uses cheap and readily
available bulk chemicals, thereby providing an affordable synthesis of the drug for cheaper …
Molnupiravir (MK-4482, EIDD-2801) is an experimental drug that has been demonstrated to be effective for the treatment of COVID-19 in human clinical trials. Herein, we report a concise synthesis of the drug via a novel thionated derivative that relies on one-pot methodologies, thus decreasing the number of purification steps required. This route provides the drug in an overall 62% yield and >99% purity and uses cheap and readily available bulk chemicals, thereby providing an affordable synthesis of the drug for cheaper and wider global accessibility.
ACS Publications以上显示的是最相近的搜索结果。 查看全部搜索结果